TLDR: OpenAI co-founder Sam Altman is backing Merge Labs, a new brain-computer interface (BCI) startup, in a $250 million funding round, positioning it as a direct competitor to Elon Musk’s Neuralink. The venture aims to integrate human cognition with artificial intelligence through advanced neural implants, further escalating the rivalry between the two tech titans.
Sam Altman, co-founder of OpenAI, is intensifying his long-standing rivalry with Elon Musk by throwing his support behind Merge Labs, a burgeoning venture in the brain-computer interface (BCI) sector. This move positions Merge Labs as a direct challenger to Musk’s Neuralink, with the startup reportedly seeking to raise $250 million in funding, primarily from OpenAI’s venture capital arm.
Merge Labs, currently valued at approximately $850 million, is focused on developing advanced neural implants designed to seamlessly merge human cognition with artificial intelligence systems. The company’s ambition is to revolutionize fields such as medicine, communication, and human augmentation by enabling direct interaction between the human brain and AI.
Sources familiar with the matter indicate that while Altman is listed as a co-founder of Merge Labs, he will not be involved in its day-to-day operations nor will he contribute personal funds. The investment, however, aligns with Altman’s broader vision of accelerating human-AI symbiosis, echoing his public statements on the transformative potential of AI.
The competition between Altman and Musk has deep roots, stemming from their shared history at OpenAI, which Musk co-founded before departing due to disagreements over the company’s direction. Their rivalry has since extended to various domains, including AI ethics and corporate governance. While Neuralink recently achieved significant milestones, such as enabling a paralyzed patient to control a computer cursor with thoughts, Merge Labs is reportedly pursuing less invasive implantation methods compared to Neuralink’s threaded electrodes, potentially mitigating risks like brain tissue damage.
Also Read:
- Altman Accuses Musk of X Algorithm Manipulation Amid Apple App Store Feud
- Elon Musk’s xAI Threatens Legal Action Against Apple Over Alleged App Store Antitrust Violations Favoring OpenAI
As reported by Quartz, Merge Labs aims to ‘merge humans and machines through artificial intelligence,’ a goal that resonates with Altman’s prior expressed interest in neurotechnology that could enhance cognitive abilities or even facilitate consciousness uploading. This strategic investment underscores the accelerating race to integrate human biology with advanced AI, promising profound implications for the future of technology and humanity.
